NEWS

  • VGS Initiates U.S. Pivotal Trial to Evaluate the Use of Its VEST Technology for Bypass Surgery

    April 23, 2018

    TEL AVIV, Israel, April 23, 2018 /PRNewswire/ -- Vascular Graft Solutions Ltd (VGS) announces on enrollment of the first 20 patients into the VEST US pivotal trial that will evaluate the safety and ef...

    Read More
  • Herantis Pharma announces positive interim data from Lymfactin study in secondary lymphedema

    April 16, 2018

    Herantis Pharma PlcCompany release 16 Apr 2018 at 9:00 am Herantis Pharma Plc (“Herantis”) announced today positive results from a safety evaluation in the ongoing Phase 1 clinical study assessin...

    Read More
  • CellAegis Announces First Patients Enrolled in U.S. Shield Pivotal Clinical Trial

    April 10, 2018

    TORONTO, Canada, April 10, 2018 (GLOBE NEWSWIRE) – CellAegis Devices Inc. (“CellAegis” or the “Company”), a commercial-stage medical device company advancing innovative, non-invasive, safe a...

    Read More
  • Broadview Ventures 2017 Annual Report

    March 20, 2018

    Broadview Ventures 2017 Annual Report...

    Read More
  • Acesion Pharma Commences Phase 1 Study in Atrial Fibrillation

    March 12, 2018

    COPENHAGEN, Denmark— 12 March 2018: Acesion Pharma (“Acesion” or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most common cardiac ...

    Read More
  • Vectorious closes B round, setting stage for trials of heart-monitoring implant

    March 8, 2018

    Vectorious Medical Technologies has raised cash to trial an implant for monitoring left atrial pressure in congestive heart failure patients, Globes reports. The series B round will fund a device the...

    Read More
  • Acesion Pharma Receives Approval for Phase I Study in Atrial Fibrillation

    February 8, 2018

    COPENHAGEN, Denmark— 8 February 2018: Acesion Pharma (“Acesion” or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most common cardiac arrhyt...

    Read More
  • ZZ Biotech Announces Preliminary Phase 2 Stroke Trial Results

    January 29, 2018

    ZZ Biotech Announces Preliminary Phase 2 Stroke Trial Results with 3K3A-APC Houston, TX, USA, January 29, 2018 / B3C newswire / -- ZZ Biotech today announced that preliminary results of RHAPSODY, the...

    Read More
  • 480 Biomedical’s Novel Technology Featured in Nature Materials

    November 21, 2017

    480 Biomedical develops new technology which imparts metal-like strength on bioresorbable polymers WATERTOWN, Mass., Nov. 21, 2017 (GLOBE NEWSWIRE) -- 480 Biomedical, a clinical-stage life science c...

    Read More
  • Boston Scientific Announces Agreement to Acquire Apama Medical

    October 10, 2017

    Acquisition to Strengthen Company's Electrophysiology Portfolio and Expand into "Single-Shot" Balloon Pulmonary Vein Isolation Treatments for Patients with Atrial Fibrillation Oct 2, 2017 MARL...

    Read More